RSNA 2005 

Abstract Archives of the RSNA, 2005


SST18-04

Early and Delayed Planar, SPECT and SPECT/CT Scintigraphy with Tc-99m Sestamibi for the Localization of Parathyroid Adenoma in Patients with Primary Hyperparathyroidism: An Interim Analysis

Scientific Papers

Presented on December 2, 2005
Presented as part of SST18: Nuclear Medicine (Central Nervous System and Endocrine Disease: Use of PET and Single Photon Methods)

Participants

William C. Lavely MD, Presenter: Nothing to Disclose
Sibyll Goetze MD, Abstract Co-Author: Nothing to Disclose
Kent P. Friedman MD, Abstract Co-Author: Nothing to Disclose
Jeffrey P. Leal BS, Abstract Co-Author: Nothing to Disclose
Samuel P Pak MD, Abstract Co-Author: Nothing to Disclose
Zhe Zhang PhD, Abstract Co-Author: Nothing to Disclose
Elizabeth Garrett-Mayer PHD, Abstract Co-Author: Nothing to Disclose
Alan Dackiw MD, Abstract Co-Author: Nothing to Disclose
Martha A Zeiger MD, Abstract Co-Author: Nothing to Disclose
Harvey A. Ziessman MD, Abstract Co-Author: Nothing to Disclose
et al, Abstract Co-Author: Nothing to Disclose

PURPOSE

This interim analysis evaluated early and late acquisition of Tc-99m sestamibi planar, SPECT and SPECT/CT images in patients with primary hyperparathyroidism, seeking to determine the optimal imaging protocol for pre-operative parathyroid adenoma localization.

METHOD AND MATERIALS

Sixty-seven sequential patients were referred for Tc-99m sestamibi parathyroid scintigraphy; 40 underwent surgery and were analyzed. At 15 minutes and 2 hours post-injection, anterior, RAO and LAO planar and SPECT/CT images were acquired. Six image sets were anonymized. Two reading groups (two nuclear medicine physicians in each) read the six image sets as well as combinations of two image sets (19 different readings) to determine the presence or absence of an adenoma at 13 locations. Each image set or combination set was scored using a 5 point scale for certainty of focus and location. Surgical location was the gold standard. Data were analyzed using logistic regression with inferences based on accuracy (AUC of ROC curve), PPV and NPV, as well as correlation with patient characteristics. Scores of 1-3 were considered negative and 4-5 positive.

RESULTS

The kappa value comparing reading groups was 0.72; lowest kappa values were for planar images while highest kappa values were for combinations which included SPECT and SPECT/CT. Overall lateralization AUC, PPV and NPV were 84.8%, 99.3% and 74.1%, respectively. Overall precise localization AUC, PPV and NPV were 74.9%, 75.3% and 95.5%, respectively. Highest AUC was found in combination image sets which included SPECT and SPECT/CT at either early or late time points; the most accurate image sets were combinations of early SPECT/CT-late planar and early SPECT/CT-late SPECT (P<0.05 in 9 of 19 image sets). Statistically significant PPVs were found only in combination image sets that included SPECT or SPECT/CT; the image set with the highest PPV was early SPECT-late SPECT/CT (PPV = 85.3%). Significant correlations occurred between certainty of focus and mass of gland (P<0.0001), location (P<0.0001), gender (P=0.0005) and PTH level (P<0.0001).

CONCLUSION

Parathyroid localization using Tc-99m sestamibi scintigraphy should include both early and late SPECT and/or SPECT/CT acquisition.

Cite This Abstract

Lavely, W, Goetze, S, Friedman, K, Leal, J, Pak, S, Zhang, Z, Garrett-Mayer, E, Dackiw, A, Zeiger, M, Ziessman, H, et al, , Early and Delayed Planar, SPECT and SPECT/CT Scintigraphy with Tc-99m Sestamibi for the Localization of Parathyroid Adenoma in Patients with Primary Hyperparathyroidism: An Interim Analysis.  Radiological Society of North America 2005 Scientific Assembly and Annual Meeting, November 27 - December 2, 2005 ,Chicago IL. http://archive.rsna.org/2005/4414045.html